Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID.
Saved in:
| Title: | Immune dysregulation and endothelial dysfunction associate with a pro-thrombotic profile in Long COVID. |
|---|---|
| Authors: | Simón-Rueda A; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Infectious Diseases Unit, Internal Medicine Service, Hospital Clínico San Carlos, Madrid, Spain., Sánchez-Menéndez C; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain., Casado G; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Infectious Diseases Unit, Internal Medicine Service, Hospital Clínico San Carlos, Madrid, Spain., Fuertes D; School of Telecommunications Engineering, Universidad Politécnica de Madrid, Madrid, Spain., Murciano-Antón MA; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.; Family Medicine Service, Primary Healthcare Center Doctor Pedro Laín Entralgo, Madrid, Spain., Mateos E; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain., Domínguez-Mateos S; PhD Program in Biomedical Sciences and Public Health, Universidad Nacional de Educación a Distancia (UNED), Madrid, Spain.; Family Medicine Service, Primary Healthcare Center Arroyomolinos, Madrid, Spain., Pozo F; Respiratory Viruses Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Epidemiology and Public Health (CIBERESP), Instituto de Salud Carlos III, Madrid, Spain., García-Pérez J; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; AIDS Immunopathology Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Pérez-Olmeda M; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; Serology Service, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain., Cervero M; School of Medicine, Universidad Alfonso X El Sabio, Madrid, Spain., Massanella M; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; IrsiCaixa AIDS Research Institute, Germans Trias i Pujol Research Institute (IGTP), Can Ruti Campus, Barcelona, Spain.; REICOP, Spanish Network for Persistent COVID Research, Madrid, Spain., Moncunill G; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; REICOP, Spanish Network for Persistent COVID Research, Madrid, Spain.; Instituto de Salud Global de Barcelona (ISGLOBAL), Barcelona, Spain.; Facultat de Medicina i Ciències de la Salut, Universitat de Barcelona (UB), Barcelona, Spain., Torres M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; REICOP, Spanish Network for Persistent COVID Research, Madrid, Spain., Coiras M; Immunopathology and Viral Reservoir Unit, National Center of Microbiology, Instituto de Salud Carlos III, Madrid, Spain.; Biomedical Research Center Network in Infectious Diseases (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.; REICOP, Spanish Network for Persistent COVID Research, Madrid, Spain. |
| Source: | Frontiers in immunology [Front Immunol] 2025 Oct 16; Vol. 16, pp. 1613195. Date of Electronic Publication: 2025 Oct 16 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
